Acadia Pharmaceuticals (ACAD) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.47% |
| Dec 31, 2025 | -3.89% |
| Sep 30, 2025 | -15.14% |
| Jun 30, 2025 | -11.91% |
| Mar 31, 2025 | -7.22% |
| Dec 31, 2024 | 5.80% |
| Sep 30, 2024 | 4.18% |
| Jun 30, 2024 | 3.87% |
| Mar 31, 2024 | 3.18% |
| Dec 31, 2023 | 6.87% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | 13.48% |
| Mar 31, 2023 | 15.61% |
| Dec 31, 2022 | 17.73% |
| Sep 30, 2022 | 16.83% |
| Jun 30, 2022 | 16.31% |
| Mar 31, 2022 | 16.76% |
| Dec 31, 2021 | 21.17% |
| Sep 30, 2021 | 22.12% |
| Jun 30, 2021 | 25.99% |
| Mar 31, 2021 | 30.05% |
| Dec 31, 2020 | 32.98% |
| Sep 30, 2020 | 32.44% |
| Jun 30, 2020 | 29.83% |
| Mar 31, 2020 | 23.30% |
| Dec 31, 2019 | 41.89% |
| Sep 30, 2019 | 44.26% |
| Jun 30, 2019 | 46.96% |
| Mar 31, 2019 | 47.08% |
| Dec 31, 2018 | 41.71% |
| Sep 30, 2018 | 47.07% |
| Jun 30, 2018 | 97.44% |
| Mar 31, 2018 | 146.11% |
| Dec 31, 2017 | 129.29% |
| Sep 30, 2017 | 116.42% |
| Jun 30, 2017 | 104.57% |
| Mar 31, 2017 | 95.67% |
| Dec 31, 2016 | 82.79% |
| Sep 30, 2016 | 77.16% |
| Jun 30, 2016 | 69.35% |
| Dec 31, 2015 | 38.91% |